Literature DB >> 10502825

Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization.

A Sawa1, G W Wiegand, J Cooper, R L Margolis, A H Sharp, J F Lawler, J T Greenamyre, S H Snyder, C A Ross.   

Abstract

Huntington disease (HD) is a genetically dominant condition caused by expanded CAG repeats coding for glutamine in the HD gene product huntingtin. Although HD symptoms reflect preferential neuronal death in specific brain regions, huntingtin is expressed in almost all tissues, so abnormalities outside the brain might be expected. Although involvement of nuclei and mitochondria in HD pathophysiology has been suggested, specific intracellular defects that might elicit cell death have been unclear. Mitochondria dysfunction is reported in HD brains; mitochondria are organelles that regulates apoptotic cell death. We now report that lymphoblasts derived from HD patients showed increased stress-induced apoptotic cell death associated with caspase-3 activation. When subjected to stress, HD lymphoblasts also manifested a considerable increase in mitochondrial depolarization correlated with increased glutamine repeats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502825     DOI: 10.1038/13518

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  100 in total

1.  Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Authors:  Ferdinando Squitieri; Vittorio Maglione; Sara Orobello; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2011-04-26       Impact factor: 3.575

Review 2.  Nitric oxide-GAPDH-Siah: a novel cell death cascade.

Authors:  Makoto R Hara; Solomon H Snyder
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

3.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

4.  trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Authors:  Jinrong Fu; Jing Jin; Robert H Cichewicz; Serena A Hageman; Trevor K Ellis; Lan Xiang; Qi Peng; Mali Jiang; Nicolas Arbez; Katelyn Hotaling; Christopher A Ross; Wenzhen Duan
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

5.  Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington's disease.

Authors:  Laura Ciarlo; Valeria Manganelli; Paola Matarrese; Tina Garofalo; Antonella Tinari; Lucrezia Gambardella; Matteo Marconi; Maria Grasso; Roberta Misasi; Maurizio Sorice; Walter Malorni
Journal:  J Lipid Res       Date:  2012-07-06       Impact factor: 5.922

6.  A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease.

Authors:  Gen Tamiya; Satoshi Makino; Makiko Hayashi; Akiko Abe; Chikahiko Numakura; Masao Ueki; Atsushi Tanaka; Chizuru Ito; Kiyotaka Toshimori; Nobuhiro Ogawa; Tomoya Terashima; Hiroshi Maegawa; Daijiro Yanagisawa; Ikuo Tooyama; Masayoshi Tada; Osamu Onodera; Kiyoshi Hayasaka
Journal:  Am J Hum Genet       Date:  2014-08-21       Impact factor: 11.025

7.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

8.  Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.

Authors:  H Li; S H Li; Z X Yu; P Shelbourne; X J Li
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

9.  Investigation of tRNA(Leu/Lys) and ATPase 6 genes mutations in Huntington's disease.

Authors:  Sadaf Kasraie; Massoud Houshmand; Mohammad Mehdi Banoei; Solmaz Etemad Ahari; Mehdi Shafa Shariat Panahi; Parvin Shariati; Mohammad Bahar; Mostafa Moin
Journal:  Cell Mol Neurobiol       Date:  2008-04-02       Impact factor: 5.046

10.  GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation.

Authors:  Nilkantha Sen; Makoto R Hara; Abdullah Shafique Ahmad; Matthew B Cascio; Atsushi Kamiya; Jeffrey T Ehmsen; Nishant Agrawal; Nishant Aggrawal; Lynda Hester; Sylvain Doré; Solomon H Snyder; Akira Sawa
Journal:  Neuron       Date:  2009-07-16       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.